Indrayani Biotech Limited has announced that the Registrar of Companies (ROC), Chennai, has granted the company an extension of two months to hold its 34th Annual General Meeting (AGM). The AGM, originally due by September 30, 2026, for the financial year ended March 31, 2026, will now be held by November 30, 2026. This extension is to accommodate planning for a capital restructuring, including a Rights Issue, which requires multiple statutory and regulatory approvals.
AGM Timeline Extended
Indrayani Biotech Limited has received an official extension from the Registrar of Companies (ROC), Chennai, for its upcoming Annual General Meeting (AGM). The company will now have an additional two months to conduct its 34th AGM, pushing the deadline to November 30, 2026. This extension applies to the financial year that concluded on March 31, 2026.
Reasons for Extension
The need for this extension arises from the company’s ongoing efforts to plan a capital restructuring, which includes the proposed undertaking of a Rights Issue. The process involves securing numerous statutory and regulatory approvals, a timeline that necessitates the postponement of the AGM beyond the original September 30, 2026 deadline.
Future AGM Date
While the new deadline is November 30, 2026, the exact date for the AGM within this extended period will be finalized by the Board of Directors. This date will be communicated to the Stock Exchange in due course, ensuring timely information for all stakeholders.
Source: BSE
